Publications by authors named "Takashi Mima"

Background: Heterotopic gastrointestinal cysts have gastrointestinal epithelium in the cyst wall and rarely occur in the oral cavity. Most are found in the neonatal period. However, heterotopic gastrointestinal cysts that are diagnosed as a congenital tongue cyst by routine ultrasonography are extremely rare.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify risk factors for biochemical recurrence (BCR) in prostate cancer patients undergoing salvage radiation therapy (SRT) after radical prostatectomy (RP).
  • Researchers analyzed data from 122 Japanese patients and found that 45.9% experienced BCR after SRT, with significant associations from factors like microvascular invasion and pre-SRT PSA levels.
  • The findings suggest that using specific risk factors, particularly microvascular invasion and higher pre-SRT PSA, can help better predict the likelihood of BCR after SRT treatment.
View Article and Find Full Text PDF

A 60-year-old woman presented with a painless swelling in the right preauricular region. Physical examination revealed a soft, nontender, oval-shaped lump in this location. Computed tomography indicated an anterolateral cystic lesion that was attached to the condyle of the mandible and to the accessory parotid gland.

View Article and Find Full Text PDF

Primary small-cell carcinoma arising from the bladder (SmCCB) is uncommon. It differs from urothelial carcinoma (UC), the most common type of bladder cancer, with respect to its cell of origin, biology, and prognosis. Biologically, prostatic SmCCB is much more aggressive than UC, and the prognosis for cases with distant metastasis is especially poor.

View Article and Find Full Text PDF

We report a 53-year-old female patient with an unresectable metastasis to the supraclavicular lymph node from a primary gingival carcinoma of the mandible. The patient had a history of tongue carcinoma and had undergone a radical neck dissection for the treatment of gingival carcinoma. She underwent combined chemotherapy consisting of S-1 (80 mg on days 1-14, followed by a 7-day rest), docetaxel (35mg/m2 by intravenous infusion on days 1 and 8), and CDDP (10mg/m2 by intravenous infusion on days 1 and 8) every 3 weeks.

View Article and Find Full Text PDF